QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
NASDAQ:FAB

First Trust Multi Cap Value AlphaDEX Fund (FAB) Price, Holdings, & News

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)
Free FAB Stock Alerts
$78.37
+0.91 (+1.17%)
(As of 03:59 PM ET)
Compare
Today's Range
$78.20
▼
$78.40
50-Day Range
$75.50
▼
$82.62
52-Week Range
$64.89
▼
$82.62
Volume
3,314 shs
Average Volume
5,661 shs
Market Capitalization
$152.82 million
Assets Under Management
$151.18 million
Dividend Yield
1.89%
Net Expense Ratio
0.67%
Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestSocial Media
FAB stock logo

About First Trust Multi Cap Value AlphaDEX Fund (NASDAQ:FAB)

The First Trust Multi Cap Value AlphaDEX Fund (FAB) is an exchange-traded fund that is based on the NASDAQ AlphaDEX Multi Cap Value index. The fund tracks an index that uses fundamental factors to select and weight value stocks from the Nasdaq US Select Indices. FAB was launched on May 8, 2007 and is managed by First Trust.

FAB Stock Price History

FAB ETF News Headlines

December 22, 2023 | msn.com
First Trust Mid Cap Core AlphaDEX® Fund declares $0.4394 dividend
May 18, 2023 | wsj.com
First Trust Multi Cap Growth AlphaDEX Fund
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
April 28, 2023 | seekingalpha.com
FAB First Trust Multi Cap Value AlphaDEX® Fund ETF
January 7, 2023 | fool.com
First Trust Exchange-Traded AlphaDEX Fund - First Trust Large Cap Growth AlphaDEX Fund (NASDAQ: FTC)
December 23, 2022 | msn.com
First Trust Brazil AlphaDEX Fund declares quarterly distribution of $0.1018
December 23, 2022 | msn.com
First Trust Multi Cap Value AlphaDEX Fund declares quarterly distribution of $0.4778
September 23, 2022 | nasdaq.com
Analysts See 28% Upside For The Holdings of FAB
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
August 22, 2022 | finance.yahoo.com
Is First Trust Multi Cap Value AlphaDEX ETF (FAB) a Strong ETF Right Now?
See More Headlines
Receive FAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for First Trust Multi Cap Value AlphaDEX Fund and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
First Trust
Fund Name
First Trust Multi Cap Value AlphaDEX Fund
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:FAB
Inception Date
5/8/2007
Fund Manager
Daniel J. Lindquist, Jon Erickson David McGarel, RogerTestin, Stan Ueland, Chris Peterson, Erik Russo
Web
N/A
Phone
14089961010

Fund Focus

Asset Class
Equity
Benchmark
Nasdaq AlphaDEX Multi Cap Value Index
Category
Broad Equity
Focus
Size and Style
Development Level
Developed Markets
Region
North America
Number of Holdings
675

Fund Statistics

Assets Under Management
$151.18 million
Average Daily Volume
$4,128.40
Discount/Premium
-0.07%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
First Trust Advisors L.P.
Custodian
The Bank of New York Mellon Corporation
Distributor
First Trust Portfolios L.P.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Susquehanna

Options

Optionable
N/A
Short Interest
300 shs

Miscellaneous

Outstanding Shares
1,950,000
Beta
1.22
Creation Unit
50,000
Creation Fee
$1,500.00
10 Best Cheap Stocks to Buy Now Cover
10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report
Ad Behind the Markets
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Find out more here >>>

First Trust Multi Cap Value AlphaDEX Fund Expenses

TypeFABSize and Style ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.50%0.47%0.54%0.48%0.51%
Other Expenses0.17%0.69%0.54%0.34%0.58%
Total Expense0.67%0.63%0.70%0.58%0.70%
Fee Waiver0.00%-0.69%-0.55%-0.22%-0.57%
Net Expense0.67%0.49%0.60%0.54%0.58%

First Trust Multi Cap Value AlphaDEX Fund (FAB) Holdings & Exposure

Top 10 FAB Holdings

FAB Sector Exposure

FAB Industry Exposure

Full Holdings Details

FAB ETF - Frequently Asked Questions

How have FAB shares performed in 2024?

First Trust Multi Cap Value AlphaDEX Fund's stock was trading at $78.04 on January 1st, 2024. Since then, FAB shares have increased by 0.3% and is now trading at $78.29.
View the best growth stocks for 2024 here.

Are investors shorting First Trust Multi Cap Value AlphaDEX Fund?

First Trust Multi Cap Value AlphaDEX Fund saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 300 shares, an increase of 200.0% from the March 15th total of 100 shares. Based on an average daily volume of 5,700 shares, the days-to-cover ratio is presently 0.1 days.
View First Trust Multi Cap Value AlphaDEX Fund's Short Interest.

How often does First Trust Multi Cap Value AlphaDEX Fund pay dividends? What is the dividend yield for First Trust Multi Cap Value AlphaDEX Fund?

First Trust Multi Cap Value AlphaDEX Fund declared a quarterly dividend on Wednesday, March 20th. Shareholders of record on Friday, March 22nd will be paid a dividend of $0.243 per share on Thursday, March 28th. This represents a $0.97 dividend on an annualized basis and a dividend yield of 1.24%. The ex-dividend date is Thursday, March 21st.
Read our dividend analysis for FAB.

What does FAB invest in?

First Trust Multi Cap Value AlphaDEX Fund is a equity fund issued by First Trust. FAB focuses on size and style investments and follows the Nasdaq AlphaDEX Multi Cap Value Index. The fund's investments total to approximately $151.18 million assets under management.

What stocks does First Trust Multi Cap Value AlphaDEX Fund hold?

FAB invests in 675 holdings. Some of the stocks in their portfolio include KeyCorp (KEY), Citizens Financial Group (CFG), Archer-Daniels-Midland (ADM), Bunge Global (BG), Phillips 66 (PSX), Mosaic (MOS), Huntington Bancshares (HBAN), Marathon Oil (MRO), Ovintiv (OVV) and Packaging Co. of America (PKG).

What is the management fee for First Trust Multi Cap Value AlphaDEX Fund?

First Trust Multi Cap Value AlphaDEX Fund's management fee is 0.50% and has other expenses of 0.17%. The net expense ratio for FAB is 0.67%.

What other stocks do shareholders of First Trust Multi Cap Value AlphaDEX Fund own?

Based on aggregate information from My MarketBeat watchlists, some companies that other First Trust Multi Cap Value AlphaDEX Fund investors own include Spectrum Pharmaceuticals (SPPI), B&G Foods (BGS), Baxter International (BAX), Bank of America (BAC), Broadcom (AVGO), Ares Capital (ARCC), Aberdeen Total Dynamic Dividend Fund (AOD), AGNC Investment (AGNC), AES (AES) and Automatic Data Processing (ADP).

Who are First Trust Multi Cap Value AlphaDEX Fund's major shareholders?

First Trust Multi Cap Value AlphaDEX Fund's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include NBC Securities Inc. (0.47%) and Quad Cities Investment Group LLC (0.46%).

How do I buy shares of First Trust Multi Cap Value AlphaDEX Fund?

Shares of FAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:FAB) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media